- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Novartis’ iptacopan reduces proteinuria in rare renal disease trial 

C3G is a rare renal disease that affects young patients characterised by complement dysregulation. Credit: Robina Weermeijer on Unsplash.